29 results
ARS
2023 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 24
Annual report to shareholders
4:27pm
149 Item 10. Directors, Executive Officers and Corporate Governance 149 Item 11. Executive Compensation 149 Item 12. Security Ownership of Certain … governance and are reviewed quarterly by our Board of Directors. As of December 31, 2023, we've implemented a set of comprehensive cybersecurity and data
ARS
2022 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 23
Annual report to shareholders
4:08pm
. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 133 Part III 134 Item 10. Directors, Executive Officers and Corporate Governance 134 Item … , and other accompanying compliance and governance costs). Other Income (Expense), Net Other income (expense), net primarily consists of (i) interest
CORRESP
gzk4mlnv pb2
13 Apr 23
Correspondence with SEC
12:00am
8-K
ylh7tr94hxude1 n0fm9
7 Dec 22
Departure of Directors or Certain Officers
8:49am
8-K
3543u5b s1
12 Oct 22
Departure of Directors or Certain Officers
4:21pm
8-K
dx27x2uuz4fiz57lfkk
4 Jan 22
Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
4:15pm
8-K
EX-99.1
fdabuaxafd0r7fij gh
4 Jan 22
Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
4:15pm
8-K
b5uzpqctcn8l1gvzg pb
12 Aug 21
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors
4:01pm
DEF 14A
zdp rm5kfj
30 Apr 21
Definitive proxy
4:03pm
10-K
oa193ssx
31 Mar 21
Annual report
5:01pm